((自动化翻译由路透提供，请见免责声明 )) (更新)
9月12日 - ** 莫德纳 下跌18.7%，创下64.62美元的四年新低
** 疫苗生产商预计 (link) 25财年销售额为25亿至35亿美元，低于分析师预计的37.4亿美元 - LSEG
** 该公司将其收支平衡目标推迟了两年，因为它推迟了几种关键产品的开发时间，并预测 2025 年的销售额低于今年的预测。
** 公司预计在2028年实现运营现金成本收支平衡，比之前的预期晚两年
** 首席财务官詹姆斯-莫克（James Mock）说，25 财年的 预测反映了美国 COVID 和呼吸道合胞病毒市场的不确定性 。
** 补充说，公司已将 2027 年之前批准的 10 种新产品将于 2028 年开始产生有意义的收入这一预测考虑在内。
** 包括盘中走势在内，该股今年累计下跌33.9
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.